Methylsulfonylmethane enhances MSC chondrogenic commitment and promotes pre-osteoblasts formation
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 12 (1), 1-12
- https://doi.org/10.1186/s13287-021-02396-5
Abstract
Background Methylsulfonylmethane (MSM) is a nutraceutical compound which has been indicated to counteract osteoarthritis, a cartilage degenerative disorder. In addition, MSM has also been shown to increase osteoblast differentiation. So far, few studies have investigated MSM role in the differentiation of mesenchymal stem cells (MSCs), and no study has been performed to evaluate its overall effects on both osteogenic and chondrogenic differentiation. These two mutually regulated processes share the same progenitor cells. Methods Therefore, with the aim to evaluate the effects of MSM on chondrogenesis and osteogenesis, we analyzed the expression of SOX9, RUNX2, and SP7 transcription factors in vitro (mesenchymal stem cells and chondrocytes cell lines) and in vivo (zebrafish model). Real-time PCR as well Western blotting, immunofluorescence, and specific in vitro and in vivo staining have been performed. Student’s paired t test was used to compare the variation between the groups. Results Our data demonstrated that MSM modulates the expression of differentiation-related genes both in vitro and in vivo. The increased SOX9 expression suggests that MSM promotes chondrogenesis in treated samples. In addition, RUNX2 expression was not particularly affected by MSM while SP7 expression increased in all MSM samples/model analyzed. As SP7 is required for the final commitment of progenitors to preosteoblasts, our data suggest a role of MSM in promoting preosteoblast formation. In addition, we observed a reduced expression of the osteoclast-surface receptor RANK in larvae and in scales as well as a reduced pERK/ERK ratio in fin and scale of MSM treated zebrafish. Conclusions In conclusion, our study provides new insights into MSM mode of action and suggests that MSM is a useful tool to counteract skeletal degenerative diseases by targeting MSC commitment and differentiation.Keywords
This publication has 53 references indexed in Scilit:
- MicroRNA-146 function in the innate immune transcriptome response of zebrafish embryos to Salmonella typhimurium infectionBMC Genomics, 2013
- Micro RNA ‐146b promotes adipogenesis by suppressing the SIRT 1‐ FOXO 1 cascadeEMBO Molecular Medicine, 2013
- MSM Enhances GH Signaling via the Jak2/STAT5b Pathway in Osteoblast-Like Cells and Osteoblast Differentiation through the Activation of STAT5b in MSCsPLOS ONE, 2012
- Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal modelJournal of Bone and Mineral Metabolism, 2012
- Twist Controls Skeletal Development and Dorsoventral Patterning by Regulating Runx2 in ZebrafishPLOS ONE, 2011
- Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?Journal of Signal Transduction, 2011
- Cartilage homeostasis in health and rheumatic diseasesArthritis Research & Therapy, 2009
- Regulation of zebrafish fin regeneration by microRNAsProceedings of the National Academy of Sciences of the United States of America, 2008
- CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiationThe Journal of cell biology, 2008
- Stages of embryonic development of the zebrafishDevelopmental Dynamics, 1995